Semaglutide or Zepbound®: Navigating The Landscape of GLP-1’s
Table of Contents Introduction The treatment landscape for chronic conditions like type 2 diabetes and obesity has transformed dramatically in recent decades. As these diseases continue to rise globally, finding effective treatments has become a top priority in healthcare. One of the most significant advancements in this area is the development of GLP-1 (Glucagon-like Peptide-1) …